Sign In
Buy ABT
$100.79
+0.200 (+0.199%)
At Close: Jul 23, 2026
ISRG vs. ABT: Which MedTech Giant Is the Smarter Investment Now?
03:11pm, Thursday, 23'rd Jul 2026
ISRG's expanding robotic surgery ecosystem and innovation pipeline give it an edge over Abbott for investors seeking stronger long-term MedTech growth.
23,500 Shares in Abbott Laboratories $ABT Purchased by B&D White Capital Company LLC
05:15am, Thursday, 23'rd Jul 2026
B&D White Capital Company LLC bought a new stake in shares of Abbott Laboratories (NYSE: ABT) during the undefined quarter, according to the company in its most recent Form 13F filing with the Securit
Abbott Laboratories $ABT Shares Acquired by ABN Amro Investment Solutions
03:49am, Thursday, 23'rd Jul 2026
ABN Amro Investment Solutions increased its stake in Abbott Laboratories (NYSE: ABT) by 10.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission.
3 Reasons to Buy AbbVie Stock Like There's No Tomorrow
06:30pm, Tuesday, 21'st Jul 2026
It looks like a great buy-and-hold option.
Johnson & Johnson vs Abbott Laboratories: Two Healthcare Giants on Opposite Trajectories
11:00am, Tuesday, 21'st Jul 2026
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) and Abbott Laboratories (NYSE:ABT) both recently posted earnings that show two healthcare giants moving in opposite strategic directions.
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
10:02am, Tuesday, 21'st Jul 2026
Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Andra AP fonden Has $21.22 Million Stock Holdings in Abbott Laboratories $ABT
04:59am, Tuesday, 21'st Jul 2026
Andra AP fonden lowered its position in shares of Abbott Laboratories (NYSE: ABT) by 36.4% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange
Abbott Laboratories $ABT Shares Sold by AlTi Global Inc.
03:13am, Tuesday, 21'st Jul 2026
AlTi Global Inc. lowered its stake in shares of Abbott Laboratories (NYSE: ABT) by 54.7% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.
Ascent Wealth Partners LLC Reduces Position in Abbott Laboratories $ABT
05:58am, Sunday, 19'th Jul 2026
Ascent Wealth Partners LLC reduced its stake in Abbott Laboratories (NYSE: ABT) by 29.4% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Com
Assetmark Inc. Boosts Holdings in Abbott Laboratories $ABT
05:18am, Sunday, 19'th Jul 2026
Assetmark Inc. grew its stake in shares of Abbott Laboratories (NYSE: ABT) by 8.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The instit
AIA Group Ltd Boosts Holdings in Abbott Laboratories $ABT
04:43am, Sunday, 19'th Jul 2026
AIA Group Ltd grew its position in shares of Abbott Laboratories (NYSE: ABT) by 49.8% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). T
Allspring Global Investments Holdings LLC Increases Holdings in Abbott Laboratories $ABT
04:10am, Sunday, 19'th Jul 2026
Allspring Global Investments Holdings LLC raised its stake in Abbott Laboratories (NYSE: ABT) by 11.9% during the first quarter, according to the company in its most recent Form 13F filing with the Se
Abbott: Bear Trap Over, With Richer Return Prospects
11:23pm, Friday, 17'th Jul 2026
ABT's diversified diagnostics/nutrition/medtech segments drive multi-pronged growth prospects, as the management targets a +7% organic growth rate. The recent EXAS acquisition introduces balance sheet
Abbott investigates two separate cyber incidents, says no operations affected
07:02pm, Friday, 17'th Jul 2026
Abbott Laboratories is investigating two cyber incidents involving unauthorized access to some internal systems at its cancer diagnostics business and its LabCentral portal, the company said on
ABT Q2 Earnings Call Flags Stronger Second-Half Setup
11:01am, Friday, 17'th Jul 2026
Abbott's raised 2026 earnings outlook and four growth drivers point to a faster second half across nutrition, devices, diagnostics and diabetes care.
